<232> Elemental Impurities - Limits

USP Chapter <232> establishes permissible limits for elemental impurities in drug products to ensure patient safety. It specifies acceptable daily exposure values for 23 elements, outlines testing methods such as ICP-MS, and provides guidance on risk assessment and control strategies for manufacturers.